Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and manufacturing of a comprehensive pipeline of immunological agents designed to expand103.46M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States101.46M98.06%
Rest of world2M1.94%